These direct lines of evidence agree well with our observation of a drastic reduction of PK expression accompanied by an increase of cyclins levels in human patient's biopsies and the inverse relationship between PK and cyclins expressions in GBM biopsies (this work Figure 9 and 39-41). The gene discussed is PCNA; the disease is glioblastoma.